Invariant Natural Killer T-Cell Control of Type 1 Diabetes: A Dendritic Cell Genetic Decision of a Silver Bullet or Russian Roulette

OBJECTIVE: In part, activation of invariant natural killer T (iNKT)-cells with the superagonist α-galactosylceramide (α-GalCer) inhibits the development of T-cell–mediated autoimmune type 1 diabetes in NOD mice by inducing the downstream differentiation of antigen-presenting dendritic cells (DCs) to...

Descripción completa

Detalles Bibliográficos
Autores principales: Driver, John P., Scheuplein, Felix, Chen, Yi-Guang, Grier, Alexandra E., Wilson, S. Brian, Serreze, David V.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809954/
https://www.ncbi.nlm.nih.gov/pubmed/19903740
http://dx.doi.org/10.2337/db09-1116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809954/
https://www.ncbi.nlm.nih.gov/pubmed/19903740
http://dx.doi.org/10.2337/db09-1116

Ejemplares similares